Abstract
Based on recent research neuroinflammation is more than just a pathological mechanism in neurodegenerative diseases. As representatives for the cytokine family we will review the functions of Interleukin-6 and Tumor Necorosis Factor with respect to their role in neuroprotection and neurodegeneration. Both cytokines have been found to be strongly upregulated during diseases such as Alzheimers disease, stroke or Parkinsons syndrome. By comparing signaling function of these cytokines during health and disease it becomes clear that the role of cytokine mediated tissue modulation depends very much on the molecular and cellular state of nerve cells e.g. physiological vs. pathological. Finally, we will discuss the possibilities of using cytokine activated pathways as a potential targets for therapeutic avenues.
Keywords: Tumor Necrosis Factor, Interleukin-6, Nuclear Factor kappa B, Protein Kinase B/Akt, gp130, STAT
Current Signal Transduction Therapy
Title: Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways
Volume: 1 Issue: 2
Author(s): Ulrich L.M. Eisel, Knut Biber and Paul G.M. Luiten
Affiliation:
Keywords: Tumor Necrosis Factor, Interleukin-6, Nuclear Factor kappa B, Protein Kinase B/Akt, gp130, STAT
Abstract: Based on recent research neuroinflammation is more than just a pathological mechanism in neurodegenerative diseases. As representatives for the cytokine family we will review the functions of Interleukin-6 and Tumor Necorosis Factor with respect to their role in neuroprotection and neurodegeneration. Both cytokines have been found to be strongly upregulated during diseases such as Alzheimers disease, stroke or Parkinsons syndrome. By comparing signaling function of these cytokines during health and disease it becomes clear that the role of cytokine mediated tissue modulation depends very much on the molecular and cellular state of nerve cells e.g. physiological vs. pathological. Finally, we will discuss the possibilities of using cytokine activated pathways as a potential targets for therapeutic avenues.
Export Options
About this article
Cite this article as:
Eisel L.M. Ulrich, Biber Knut and Luiten G.M. Paul, Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways, Current Signal Transduction Therapy 2006; 1 (2) . https://dx.doi.org/10.2174/157436206777012057
DOI https://dx.doi.org/10.2174/157436206777012057 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Beyond Cholinesterase Inhibition: Anti-Inflammatory Role and Pharmacological Profile of Current Drug Therapy for Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
Current HIV Research Inhibition of West Nile virus Replication by Bifunctional siRNA Targeting the NS2A and NS5 Conserved Region
Current Gene Therapy Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy
Current Pharmaceutical Design Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins
Current Gene Therapy An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions
Current Pharmaceutical Design Neuroinflammation: Microglial Activation During Sepsis
Current Neurovascular Research Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Current Pharmaceutical Design Hendra and Nipah Infection: Pathology, Models and Potential Therapies
Infectious Disorders - Drug Targets The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases – Part I
Current Medicinal Chemistry Human Rabies Encephalitis Prevention and Treatment: Progress Since Pasteurs Discovery
Infectious Disorders - Drug Targets Picornavirus IRES: Structure Function Relationship
Current Pharmaceutical Design Transition-State-Guided Drug Design for Treatment of Parasitic Neglected Tropical Diseases
Current Medicinal Chemistry Novel Phospholipase-Resistant Lipid/Peptide Synthetic Lung Surfactants
Mini-Reviews in Medicinal Chemistry Innate Immunity and Vaccines
Current Topics in Medicinal Chemistry Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery Epstein-Barr Encephalitis in a Child with Congenital Human Immunodeficiency Virus Infection: A Case Report Calling for No Forgetfulness
Current HIV Research Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective
Current Analytical Chemistry Editorial (Thematic Issue: Vaccines)
Recent Patents on Inflammation & Allergy Drug Discovery